Stay updated on Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3 label. This reflects a small update to the page's revision history or template without changing the study information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. This update does not change any study details or user-facing content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows revision v3.6.2 as the current version, replacing the prior v3.6.0.SummaryDifference0.0%

- Check45 days agoChange DetectedThe Publications section loses a citation for Reck et al., Pembrolizumab vs Chemotherapy in PD-L1-positive NSCLC (KEYNOTE-024, NEJM 2016).SummaryDifference0.1%

- Check52 days agoChange DetectedRecruitment status is updated to indicate no longer seeking participants. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and implements minor formatting changes to the Intervention/Treatment header, along with a new revision tag (v3.6.0).SummaryDifference0.4%

- Check59 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's version; no study details or primary content were changed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemotherapy in Lung Cancer Clinical Trial page.